Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.
第一作者:
Kazuki,Maesaka
第一单位:
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
作者:
DOI
10.1111/hepr.13741
PMID
34918428
发布时间
2022-05-18
- 浏览0

Hepatology research
298-307页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文